Table 1_Proteomic profiling of cerebrospinal fluid uncovers distinctive pathophysiological changes and potential biomarkers in pediatric tubercular meningitis.xlsx

Introduction<p>Tubercular meningitis (TBM) is a serious pediatric infection with high mortality rates. This research aimed to characterize the alterations in cerebrospinal fluid (CSF) proteome in TBM and to identify biomarker panels that can distinguish it from other central nervous system inf...

Полное описание

Сохранить в:
Библиографические подробности
Главный автор: Jing Wei (127335) (author)
Другие авторы: Liang Zhu (172992) (author), Binglin Jian (15282910) (author), Yuncui Yu (8717934) (author), Bing Hu (240996) (author), Lingyun Guo (12218542) (author), Huili Hu (10152440) (author), Zhenzhen Dou (7429280) (author), Linlin Liu (426425) (author), Gang Liu (81776) (author), Peng Guo (134478) (author)
Опубликовано: 2025
Предметы:
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!
_version_ 1851481995960385536
author Jing Wei (127335)
author2 Liang Zhu (172992)
Binglin Jian (15282910)
Yuncui Yu (8717934)
Bing Hu (240996)
Lingyun Guo (12218542)
Huili Hu (10152440)
Zhenzhen Dou (7429280)
Linlin Liu (426425)
Gang Liu (81776)
Peng Guo (134478)
author2_role author
author
author
author
author
author
author
author
author
author
author_facet Jing Wei (127335)
Liang Zhu (172992)
Binglin Jian (15282910)
Yuncui Yu (8717934)
Bing Hu (240996)
Lingyun Guo (12218542)
Huili Hu (10152440)
Zhenzhen Dou (7429280)
Linlin Liu (426425)
Gang Liu (81776)
Peng Guo (134478)
author_role author
dc.creator.none.fl_str_mv Jing Wei (127335)
Liang Zhu (172992)
Binglin Jian (15282910)
Yuncui Yu (8717934)
Bing Hu (240996)
Lingyun Guo (12218542)
Huili Hu (10152440)
Zhenzhen Dou (7429280)
Linlin Liu (426425)
Gang Liu (81776)
Peng Guo (134478)
dc.date.none.fl_str_mv 2025-10-16T05:31:57Z
dc.identifier.none.fl_str_mv 10.3389/fcimb.2025.1662783.s002
dc.relation.none.fl_str_mv https://figshare.com/articles/dataset/Table_1_Proteomic_profiling_of_cerebrospinal_fluid_uncovers_distinctive_pathophysiological_changes_and_potential_biomarkers_in_pediatric_tubercular_meningitis_xlsx/30372055
dc.rights.none.fl_str_mv CC BY 4.0
info:eu-repo/semantics/openAccess
dc.subject.none.fl_str_mv Clinical Microbiology
tuberculous meningitis
cerebrospinal fluid
proteomics
different pathogenesis
biomarker
dc.title.none.fl_str_mv Table 1_Proteomic profiling of cerebrospinal fluid uncovers distinctive pathophysiological changes and potential biomarkers in pediatric tubercular meningitis.xlsx
dc.type.none.fl_str_mv Dataset
info:eu-repo/semantics/publishedVersion
dataset
description Introduction<p>Tubercular meningitis (TBM) is a serious pediatric infection with high mortality rates. This research aimed to characterize the alterations in cerebrospinal fluid (CSF) proteome in TBM and to identify biomarker panels that can distinguish it from other central nervous system infections. </p>Methods<p>We retrospectively analyzed the CSF proteome from 104 patients, including 7 TBM, 28 with purulent meningitis (PM), 20 with viral meningitis (VM), 9 with cryptococcus neoformans meningitis (CNM), 30 non-CNS infected controls (Ctrl), and 10 brain disease (BD) controls. </p>Results<p>The TBM proteome displayed greater similarity to that of PM patients. A total of 120 cytokines and receptors were significantly dysregulated in TBM CSF. Pathway analysis indicated marked upregulation of complement activation, fibrin clot formation, and microautophagy signaling, along with significant suppression of collagen degradation in TBM. Biomarker panels were established, including F2 and TYMP to differentiate TBM from PM (AUC=0.874, 95% CI, 0.748-0.999), ENPP2 and WARS1 to differentiate TBM from VM (AUC=0.929, 95% CI, 0.929-1), F12, APOM and CD163 to differentiate TBM from CCM (AUC=0.993, 95% CI, 0.869-1), and HLA-B and MGAT1 to differentiate TBM from Ctrls (AUC=0.934, 95% CI, 0.825-1).</p>Discussion<p>This research will provide a highly valuable proteomics resource for a better understanding of TBM pathogenesis, yielding insights into important differential diagnostic biomarkers and potential therapeutic targets in pediatric TBM.</p>
eu_rights_str_mv openAccess
id Manara_fa14c3a1d35ccdda2ecfd516bd9cc23a
identifier_str_mv 10.3389/fcimb.2025.1662783.s002
network_acronym_str Manara
network_name_str ManaraRepo
oai_identifier_str oai:figshare.com:article/30372055
publishDate 2025
repository.mail.fl_str_mv
repository.name.fl_str_mv
repository_id_str
rights_invalid_str_mv CC BY 4.0
spelling Table 1_Proteomic profiling of cerebrospinal fluid uncovers distinctive pathophysiological changes and potential biomarkers in pediatric tubercular meningitis.xlsxJing Wei (127335)Liang Zhu (172992)Binglin Jian (15282910)Yuncui Yu (8717934)Bing Hu (240996)Lingyun Guo (12218542)Huili Hu (10152440)Zhenzhen Dou (7429280)Linlin Liu (426425)Gang Liu (81776)Peng Guo (134478)Clinical Microbiologytuberculous meningitiscerebrospinal fluidproteomicsdifferent pathogenesisbiomarkerIntroduction<p>Tubercular meningitis (TBM) is a serious pediatric infection with high mortality rates. This research aimed to characterize the alterations in cerebrospinal fluid (CSF) proteome in TBM and to identify biomarker panels that can distinguish it from other central nervous system infections. </p>Methods<p>We retrospectively analyzed the CSF proteome from 104 patients, including 7 TBM, 28 with purulent meningitis (PM), 20 with viral meningitis (VM), 9 with cryptococcus neoformans meningitis (CNM), 30 non-CNS infected controls (Ctrl), and 10 brain disease (BD) controls. </p>Results<p>The TBM proteome displayed greater similarity to that of PM patients. A total of 120 cytokines and receptors were significantly dysregulated in TBM CSF. Pathway analysis indicated marked upregulation of complement activation, fibrin clot formation, and microautophagy signaling, along with significant suppression of collagen degradation in TBM. Biomarker panels were established, including F2 and TYMP to differentiate TBM from PM (AUC=0.874, 95% CI, 0.748-0.999), ENPP2 and WARS1 to differentiate TBM from VM (AUC=0.929, 95% CI, 0.929-1), F12, APOM and CD163 to differentiate TBM from CCM (AUC=0.993, 95% CI, 0.869-1), and HLA-B and MGAT1 to differentiate TBM from Ctrls (AUC=0.934, 95% CI, 0.825-1).</p>Discussion<p>This research will provide a highly valuable proteomics resource for a better understanding of TBM pathogenesis, yielding insights into important differential diagnostic biomarkers and potential therapeutic targets in pediatric TBM.</p>2025-10-16T05:31:57ZDatasetinfo:eu-repo/semantics/publishedVersiondataset10.3389/fcimb.2025.1662783.s002https://figshare.com/articles/dataset/Table_1_Proteomic_profiling_of_cerebrospinal_fluid_uncovers_distinctive_pathophysiological_changes_and_potential_biomarkers_in_pediatric_tubercular_meningitis_xlsx/30372055CC BY 4.0info:eu-repo/semantics/openAccessoai:figshare.com:article/303720552025-10-16T05:31:57Z
spellingShingle Table 1_Proteomic profiling of cerebrospinal fluid uncovers distinctive pathophysiological changes and potential biomarkers in pediatric tubercular meningitis.xlsx
Jing Wei (127335)
Clinical Microbiology
tuberculous meningitis
cerebrospinal fluid
proteomics
different pathogenesis
biomarker
status_str publishedVersion
title Table 1_Proteomic profiling of cerebrospinal fluid uncovers distinctive pathophysiological changes and potential biomarkers in pediatric tubercular meningitis.xlsx
title_full Table 1_Proteomic profiling of cerebrospinal fluid uncovers distinctive pathophysiological changes and potential biomarkers in pediatric tubercular meningitis.xlsx
title_fullStr Table 1_Proteomic profiling of cerebrospinal fluid uncovers distinctive pathophysiological changes and potential biomarkers in pediatric tubercular meningitis.xlsx
title_full_unstemmed Table 1_Proteomic profiling of cerebrospinal fluid uncovers distinctive pathophysiological changes and potential biomarkers in pediatric tubercular meningitis.xlsx
title_short Table 1_Proteomic profiling of cerebrospinal fluid uncovers distinctive pathophysiological changes and potential biomarkers in pediatric tubercular meningitis.xlsx
title_sort Table 1_Proteomic profiling of cerebrospinal fluid uncovers distinctive pathophysiological changes and potential biomarkers in pediatric tubercular meningitis.xlsx
topic Clinical Microbiology
tuberculous meningitis
cerebrospinal fluid
proteomics
different pathogenesis
biomarker